You are here: Home » Reuters » News
Business Standard

Indivior loses U.S. district court battle, copycat launches imminent


(Reuters) - Generic competitors to British drugmaker Plc's blockbuster treatment are on course to launch sales next week after the firm's attempt to stay a judgement was rejected.

The company said on Tuesday it would file a repeat motion to the Supreme Court, after having said last week that it faces rapid losses in market share "in the immediate future" to generic versions of Suboxone.

Earlier this month, a mandate by the opened the gates to rivals including India's Dr. Reddy's.

(Reporting by in Bengaluru; Editing by Arun Koyyur)

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, February 12 2019. 13:00 IST